#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	4832	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2328	613.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1560	1560	C	715	C,T,A	629,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	4832	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2328	613.1	0	HET	.	.	.	C925T	.	925	925	C	1301	1301	C	710	C,T	321,307	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7784	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3918	595.9	0	.	n	.	0	T695C	SNP	695	695	T	1193	1193	C	634	C,T	558,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7784	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3918	595.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1835	1835	A	669	A,G,C	587,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7784	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3918	595.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2469	2469	C	677	C,T,A	573,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7784	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3918	595.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2543	2543	A	682	A	579	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7784	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3918	595.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3095	3095	C	717	C,T,A	611,2,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_G_01367c	folP.WHO_G_01367c	1	1	27	852	folP	852	852	100.0	folP.l6.c4.ctg.1	1893	135.1	1	SNP	p	R228S	1	.	.	682	684	AGC	1191	1193	AGC	191;190;189	A;G;C	169;167;167	folP.WHO_G_01367c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_Z_01155	gyrA.WHO_Z_01155	1	1	27	1634	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3804	128.8	1	SNP	p	S91F	1	.	.	271	273	TTC	774	776	TTC	144;146;146	T;T;C	128;129;130	gyrA.WHO_Z_01155:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_Z_01155	gyrA.WHO_Z_01155	1	1	27	1634	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3804	128.8	1	SNP	p	N95G	0	.	.	283	285	AAC	786	788	AAC	146;146;148	A;A;C	129;127;133	gyrA.WHO_Z_01155:1:1:N95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_Z_01155	gyrA.WHO_Z_01155	1	1	27	1634	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3804	128.8	1	SNP	p	D95N	1	.	.	283	285	AAC	786	788	AAC	146;146;148	A;A;C	129;127;133	gyrA.WHO_Z_01155:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	766	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1696	135.5	1	SNP	p	G45D	1	.	.	133	135	GAC	659	661	GAC	218;216;216	G;A;C	192;192;193	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	472	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1288	109.9	0	.	n	.	0	A197.	DEL	197	197	A	745	745	A	206	A,T	183,1	.	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	1706	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3346	153.0	1	SNP	p	D86N	0	.	.	256	258	GAC	779	781	GAC	225;222;222	G;A;C	192;188;191	parC.WHO_X_00208c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	1706	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3346	153.0	1	SNP	p	R87I	0	.	.	259	261	CGT	782	784	CGT	222;223;221	C;G,T;T	192;191,1;186	parC.WHO_X_00208c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	1706	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3346	153.0	1	SNP	p	S87R	1	.	.	259	261	CGT	782	784	CGT	222;223;221	C;G,T;T	192;191,1;186	parC.WHO_X_00208c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	1706	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3346	153.0	1	SNP	p	R87W	0	.	.	259	261	CGT	782	784	CGT	222;223;221	C;G,T;T	192;191,1;186	parC.WHO_X_00208c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	1706	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3346	153.0	1	SNP	p	S88P	1	.	.	262	264	CCC	785	787	CCC	222;224;224	C;C;C	190;190;190	parC.WHO_X_00208c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1428	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3022	141.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1738	1740	GGC	186;187;186	G;G;C	162;163;163	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.10.001	penA.10.001	1	1	27	1274	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2676	142.7	1	SNP	p	A311V	0	.	.	931	933	GCC	1432	1434	GCC	185;185;185	G,A;C;C,A	163,1;164;166,1	penA.10.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1274	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2676	142.7	1	SNP	p	I312M	1	.	.	934	936	ATG	1435	1437	ATG	185;185;184	A;T;G,C	166;161;160,1	penA.10.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1274	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2676	142.7	1	SNP	p	T316P	0	.	.	946	948	ACC	1447	1449	ACC	182;183;183	A,G;C,T,A;C,G	157,1;159,1,1;161,1	penA.10.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1274	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2676	142.7	1	SNP	p	V316T	1	.	.	946	948	ACC	1447	1449	ACC	182;183;183	A,G;C,T,A;C,G	157,1;159,1,1;161,1	penA.10.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1274	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2676	142.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1948	1950	ACC	184;184;185	A;C;C	168;163;166	penA.10.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1274	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2676	142.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2002	2004	GCG	176;175;175	G;C;G	153;154;154	penA.10.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1274	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2676	142.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2002	2004	GCG	176;175;175	G;C;G	153;154;154	penA.10.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1274	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2676	142.7	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2125	2127	GGT	176;176;176	G;G;T	152;151;152	penA.10.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1274	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2676	142.7	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2134	2136	AGC	173;173;172	A;G;C	152;151;149	penA.10.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1274	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2676	142.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2152	2154	CCG	164;166;164	C;C,A;G	144;143,1;144	penA.10.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1654	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3373	147.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1767	1769	CCG	174;174;174	C;C;G,T	144;144;145,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	850	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2163	117.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	755	755	C	164	C,T	145,1	.	.
porB1b.WHO_K_02195c	porB1b.WHO_K_02195c	1	1	27	1038	porB1b	1047	1047	100.0	porB1b.l15.c4.ctg.1	1833	165.4	1	SNP	p	G120K	1	.	.	358	360	AAG	861	863	AAG	185;184;184	A;A,G;G	158;158,1;157	porB1b.WHO_K_02195c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_K_02195c	porB1b.WHO_K_02195c	1	1	27	1038	porB1b	1047	1047	100.0	porB1b.l15.c4.ctg.1	1833	165.4	1	SNP	p	A121D	1	.	.	361	363	GAC	864	866	GAC	184;183;183	G,A;A;C	156,1;159;158	porB1b.WHO_K_02195c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_K_02195c	porB1b.WHO_K_02195c	1	1	27	1038	porB1b	1047	1047	100.0	porB1b.l15.c4.ctg.1	1833	165.4	1	SNP	p	D121N	0	.	.	361	363	GAC	864	866	GAC	184;183;183	G,A;A;C	156,1;159;158	porB1b.WHO_K_02195c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	3136	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5093	184.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	548	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1377	119.6	1	SNP	p	V57M	1	.	.	169	171	ATG	703	705	ATG	206;207;206	A;T;G	176;177;177	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
